Search filters

List of works by Lee S Schwartzberg

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study

scientific article published on 20 July 2020

Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United States

scientific article published on 14 November 2019

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.

scientific article published on 7 September 2017

Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.

scientific article published on 15 October 2015

Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting

scientific article published on 04 October 2018

Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III

scientific article published on 09 April 2019

G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use.

scientific article

Getting it right the first time: recent progress in optimizing antiemetic usage.

scientific article published on 19 March 2018

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.

scientific article published on 13 June 2019

Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial ⬇️

scientific article

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review

scientific article published on 03 July 2014

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy

scientific article published on 08 December 2019

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood

scientific article published on 01 September 2020

Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.

scientific article published on 13 June 2017

Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists.

scientific article published on 3 July 2018

Safety of Polysorbate 80 in the Oncology Setting.

scientific article

Paulina is supported by:

About Paulina

Help